KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Petmed Express (PETS) Invested Capital (2016 - 2025)

Petmed Express' Invested Capital history spans 15 years, with the latest figure at $32.8 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 155928.57% year-over-year to $32.8 million; the TTM value through Dec 2025 reached $32.8 million, up 155928.57%, while the annual FY2025 figure was $85.1 million, 405300.0% up from the prior year.
  • Invested Capital reached $32.8 million in Q4 2025 per PETS's latest filing, up from $23.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $132.5 million in Q2 2021 to a low of $21000.0 in Q4 2021.
  • Average Invested Capital over 5 years is $62.0 million, with a median of $77.6 million recorded in 2023.
  • Peak YoY movement for Invested Capital: skyrocketed 546900.0% in 2022, then tumbled 99.98% in 2024.
  • A 5-year view of Invested Capital shows it stood at $21000.0 in 2021, then surged by 546900.0% to $114.9 million in 2022, then crashed by 33.35% to $76.6 million in 2023, then plummeted by 99.97% to $21000.0 in 2024, then skyrocketed by 155928.57% to $32.8 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Invested Capital are $32.8 million (Q4 2025), $23.9 million (Q3 2025), and $21000.0 (Q2 2025).